Patient Outcomes at 5 and 10 Years After Neoadjuvant Chemotherapy for Stage II and III Breast Cancer Article Swipe
Catalina Falo
,
Juan Azcarate
,
Sergi Fernández-González
,
Javier Pérez
,
Ana Petit
,
H. De la Torre
,
Andrea Vethencourt
,
Silvia Guzmán Vázquez
,
María Laplana
,
M Ales
,
Agostina Stradella
,
Tomeu Fullana
,
Anna Gumà
,
Raúl Ortega
,
Mar Varela
,
Diana Perez
,
Jose Luis Ponton
,
Sara López‐Tarruella
,
Ana Benítez
,
Teresa Soler
,
Ana López-Ojeda
,
Sabela Recalde
,
E. Martinez
,
Jordi Ponce
,
Maria Jesús Pla-Farnós
,
Sònia Pernas
,
Miguel Gil‐Gil
,
Amparo Garcı́a-Tejedor
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.20944/preprints202406.0810.v1
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.20944/preprints202406.0810.v1
Introduction: Neoadjuvant chemotherapy in breast cancer offers the possibility to facilitate breast and axillary surgery, it is a test of chemosensibility in vivo with significant prognostic value and may tailor adjuvant treatment according to response. Material and Methods: a retrospective single institution of 482 stage II and III breast cancer patients treated with neoadjuvant chemotherapy based on anthracycline and taxans plus antiHEr2 in those Her2 positive cases. Survival was calculated at 5 and 10 years. Kaplan Meier with log rank test were calculated for difference according to TNM, pathological and molecular surrogated subtype, TILs cut-off 20%, response to chemotherapy and the presence of vascular invasion. Results: In the univariate those factors that influenced long-term patient outcome were TNM (p=0.000); pathologic subtype (p=0.003); Tils cut off 20%; achieving pCR (p=0.000), RCB (p=0.000) and vascular invasion (p=0.000). After a mean follow up of 126 months, Luminal tumors presented a substantial difference of survival rates calculated at 5 or 10 years (81.2% compared to 74.7%) whereas for TNBC was 75.3 and 73.5, respectively. The greatest difference was seen according to response those patients with pCR presented a 10yDDFS of 95.5 vs 72.4% for those patients without pCR. This difference was especially meaningful in TNBC were 10y DDFS according to the RCB 0 to 3 was 100%, 80.6%, 69% and 49.2% respectively. Patients with a special bad prognosis in our series were lobular carcinomas with 10y DDFS of 42.9% vs 79.7%, p= 0.001 for ductal carcinomas; and those patients with vascular invasion at the surgical specimen with a 10yDDFS of 59.2% vs 83.6, p=0.,000 for those patients without vascular invasion. Conclusion: long-term outcomes after neoadjuvant chemotherapy can help patient and clinician make well-informed decisions.
Related Topics
Concepts
Breast cancer
Stage (stratigraphy)
Chemotherapy
Oncology
Medicine
Cancer
Internal medicine
Neoadjuvant therapy
Paleontology
Biology
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.20944/preprints202406.0810.v1
- https://www.preprints.org/manuscript/202406.0810/v1/download
- OA Status
- green
- Cited By
- 1
- References
- 30
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4399749910
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4399749910Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.20944/preprints202406.0810.v1Digital Object Identifier
- Title
-
Patient Outcomes at 5 and 10 Years After Neoadjuvant Chemotherapy for Stage II and III Breast CancerWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-06-13Full publication date if available
- Authors
-
Catalina Falo, Juan Azcarate, Sergi Fernández-González, Javier Pérez, Ana Petit, H. De la Torre, Andrea Vethencourt, Silvia Guzmán Vázquez, María Laplana, M Ales, Agostina Stradella, Tomeu Fullana, Anna Gumà, Raúl Ortega, Mar Varela, Diana Perez, Jose Luis Ponton, Sara López‐Tarruella, Ana Benítez, Teresa Soler, Ana López-Ojeda, Sabela Recalde, E. Martinez, Jordi Ponce, Maria Jesús Pla-Farnós, Sònia Pernas, Miguel Gil‐Gil, Amparo Garcı́a-TejedorList of authors in order
- Landing page
-
https://doi.org/10.20944/preprints202406.0810.v1Publisher landing page
- PDF URL
-
https://www.preprints.org/manuscript/202406.0810/v1/downloadDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.preprints.org/manuscript/202406.0810/v1/downloadDirect OA link when available
- Concepts
-
Breast cancer, Stage (stratigraphy), Chemotherapy, Oncology, Medicine, Cancer, Internal medicine, Neoadjuvant therapy, Paleontology, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1Per-year citation counts (last 5 years)
- References (count)
-
30Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4399749910 |
|---|---|
| doi | https://doi.org/10.20944/preprints202406.0810.v1 |
| ids.doi | https://doi.org/10.20944/preprints202406.0810.v1 |
| ids.openalex | https://openalex.org/W4399749910 |
| fwci | 0.56791475 |
| type | preprint |
| title | Patient Outcomes at 5 and 10 Years After Neoadjuvant Chemotherapy for Stage II and III Breast Cancer |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10183 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.998199999332428 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Breast Cancer Treatment Studies |
| topics[1].id | https://openalex.org/T11752 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9886000156402588 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Treatment and Pharmacology |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C530470458 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7409230470657349 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[0].display_name | Breast cancer |
| concepts[1].id | https://openalex.org/C146357865 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7240120768547058 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[1].display_name | Stage (stratigraphy) |
| concepts[2].id | https://openalex.org/C2776694085 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6672602891921997 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[2].display_name | Chemotherapy |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6576404571533203 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5975819826126099 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C121608353 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5492541193962097 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[5].display_name | Cancer |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5030054450035095 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C2778292576 |
| concepts[7].level | 4 |
| concepts[7].score | 0.4443111717700958 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q6991934 |
| concepts[7].display_name | Neoadjuvant therapy |
| concepts[8].id | https://openalex.org/C151730666 |
| concepts[8].level | 1 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[8].display_name | Paleontology |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/breast-cancer |
| keywords[0].score | 0.7409230470657349 |
| keywords[0].display_name | Breast cancer |
| keywords[1].id | https://openalex.org/keywords/stage |
| keywords[1].score | 0.7240120768547058 |
| keywords[1].display_name | Stage (stratigraphy) |
| keywords[2].id | https://openalex.org/keywords/chemotherapy |
| keywords[2].score | 0.6672602891921997 |
| keywords[2].display_name | Chemotherapy |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.6576404571533203 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.5975819826126099 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/cancer |
| keywords[5].score | 0.5492541193962097 |
| keywords[5].display_name | Cancer |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5030054450035095 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/neoadjuvant-therapy |
| keywords[7].score | 0.4443111717700958 |
| keywords[7].display_name | Neoadjuvant therapy |
| language | en |
| locations[0].id | doi:10.20944/preprints202406.0810.v1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S6309402219 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Preprints.org |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_lineage_names | Multidisciplinary Digital Publishing Institute |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.preprints.org/manuscript/202406.0810/v1/download |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.20944/preprints202406.0810.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5059890986 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5714-6823 |
| authorships[0].author.display_name | Catalina Falo |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[0].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[0].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[0].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Catalina Falo |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[1].author.id | https://openalex.org/A5046591342 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6655-1874 |
| authorships[1].author.display_name | Juan Azcarate |
| authorships[1].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Juan Azcarate |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[2].author.id | https://openalex.org/A5014745817 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9138-6978 |
| authorships[2].author.display_name | Sergi Fernández-González |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[2].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[2].institutions[0].ror | https://ror.org/00epner96 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Bellvitge University Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sergi Fernandez |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[3].author.id | https://openalex.org/A5028382987 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-3083-4754 |
| authorships[3].author.display_name | Javier Pérez |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[3].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[3].institutions[0].ror | https://ror.org/00epner96 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Bellvitge University Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Javier Perez |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[4].author.id | https://openalex.org/A5053323713 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5769-0933 |
| authorships[4].author.display_name | Ana Petit |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[4].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[4].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[4].institutions[0].ror | https://ror.org/00epner96 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Bellvitge University Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ana Petit |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[5].author.id | https://openalex.org/A5047972347 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4516-5269 |
| authorships[5].author.display_name | H. De la Torre |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[5].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[5].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[5].institutions[0].ror | https://ror.org/00epner96 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Bellvitge University Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Hector Perez |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[6].author.id | https://openalex.org/A5083940100 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-2747-0892 |
| authorships[6].author.display_name | Andrea Vethencourt |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[6].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[6].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[6].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Andrea Vethencourt |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[7].author.id | https://openalex.org/A5031970567 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0476-4289 |
| authorships[7].author.display_name | Silvia Guzmán Vázquez |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[7].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[7].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[7].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Silvia Vazquez |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[8].author.id | https://openalex.org/A5017046778 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-9826-9494 |
| authorships[8].author.display_name | María Laplana |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[8].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Radiotherapy, Institut Català d'Oncologia, Idibell, Barcelona, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[8].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Maria Laplana |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Radiotherapy, Institut Català d'Oncologia, Idibell, Barcelona, Spain |
| authorships[9].author.id | https://openalex.org/A5113273111 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | M Ales |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[9].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[9].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[9].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[9].institutions[0].type | government |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Miriam Ales |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[10].author.id | https://openalex.org/A5062510457 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-2307-8869 |
| authorships[10].author.display_name | Agostina Stradella |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[10].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[10].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[10].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Agostina Stradella |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[11].author.id | https://openalex.org/A5099166693 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Tomeu Fullana |
| authorships[11].countries | ES |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[11].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[11].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[11].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[11].institutions[0].type | government |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[11].institutions[0].country_code | ES |
| authorships[11].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Tomeu Fullana |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[12].author.id | https://openalex.org/A5079951246 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-9390-5252 |
| authorships[12].author.display_name | Anna Gumà |
| authorships[12].countries | ES |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[12].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[12].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[12].institutions[0].ror | https://ror.org/00epner96 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[12].institutions[0].country_code | ES |
| authorships[12].institutions[0].display_name | Bellvitge University Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Anna Guma |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[13].author.id | https://openalex.org/A5112399241 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Raúl Ortega |
| authorships[13].countries | ES |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[13].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Radiology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[13].affiliations[1].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[13].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[13].institutions[0].ror | https://ror.org/00epner96 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[13].institutions[0].country_code | ES |
| authorships[13].institutions[0].display_name | Bellvitge University Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Raul Ortega |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain, Multidisciplinary Breast Cancer Unit, Department of Radiology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[14].author.id | https://openalex.org/A5014276609 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-2129-6336 |
| authorships[14].author.display_name | Mar Varela |
| authorships[14].countries | ES |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[14].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Radiotherapy, Institut Català d'Oncologia, Idibell, Barcelona, Spain |
| authorships[14].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[14].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[14].institutions[0].type | government |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[14].institutions[0].country_code | ES |
| authorships[14].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Mar Varela |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Radiotherapy, Institut Català d'Oncologia, Idibell, Barcelona, Spain |
| authorships[15].author.id | https://openalex.org/A5069513031 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-3514-9038 |
| authorships[15].author.display_name | Diana Perez |
| authorships[15].countries | ES |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[15].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[15].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[15].institutions[0].ror | https://ror.org/00epner96 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[15].institutions[0].country_code | ES |
| authorships[15].institutions[0].display_name | Bellvitge University Hospital |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Diana Perez |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[16].author.id | https://openalex.org/A5113255152 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Jose Luis Ponton |
| authorships[16].countries | ES |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210087039, https://openalex.org/I4210107147 |
| authorships[16].affiliations[0].raw_affiliation_string | Information and Data Analysis Department, Institut Català d'Oncologia,Bellvitge Research Institute (IDIBELL), Barcelona, Spain |
| authorships[16].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[16].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[16].institutions[0].type | government |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[16].institutions[0].country_code | ES |
| authorships[16].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[16].institutions[1].id | https://openalex.org/I4210087039 |
| authorships[16].institutions[1].ror | https://ror.org/0008xqs48 |
| authorships[16].institutions[1].type | facility |
| authorships[16].institutions[1].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210087039, https://openalex.org/I4210096656, https://openalex.org/I4210106543, https://openalex.org/I4210107147, https://openalex.org/I4210153292, https://openalex.org/I4387153040, https://openalex.org/I71999127 |
| authorships[16].institutions[1].country_code | ES |
| authorships[16].institutions[1].display_name | Institut d'Investigació Biomédica de Bellvitge |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Jose Luis Ponton |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Information and Data Analysis Department, Institut Català d'Oncologia,Bellvitge Research Institute (IDIBELL), Barcelona, Spain |
| authorships[17].author.id | https://openalex.org/A5044744499 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-2606-9538 |
| authorships[17].author.display_name | Sara López‐Tarruella |
| authorships[17].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Pharmacy, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Sara Cobo |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Pharmacy, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[18].author.id | https://openalex.org/A5103011493 |
| authorships[18].author.orcid | https://orcid.org/0000-0001-8258-5564 |
| authorships[18].author.display_name | Ana Benítez |
| authorships[18].countries | ES |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[18].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[18].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[18].institutions[0].ror | https://ror.org/00epner96 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[18].institutions[0].country_code | ES |
| authorships[18].institutions[0].display_name | Bellvitge University Hospital |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Ana Benitez |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[19].author.id | https://openalex.org/A5109346282 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Teresa Soler |
| authorships[19].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Teresa Soler |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[20].author.id | https://openalex.org/A5027370659 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | Ana López-Ojeda |
| authorships[20].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Reparative Surgery, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Ana Lopez-Ojeda |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Reparative Surgery, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[21].author.id | https://openalex.org/A5032577731 |
| authorships[21].author.orcid | https://orcid.org/0009-0005-4385-4115 |
| authorships[21].author.display_name | Sabela Recalde |
| authorships[21].countries | ES |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[21].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[21].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[21].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[21].institutions[0].type | government |
| authorships[21].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[21].institutions[0].country_code | ES |
| authorships[21].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Sabela Recalde |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[22].author.id | https://openalex.org/A5101492921 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-3463-5333 |
| authorships[22].author.display_name | E. Martinez |
| authorships[22].countries | ES |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[22].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Radiotherapy, Institut Català d'Oncologia, Idibell, Barcelona, Spain |
| authorships[22].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[22].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[22].institutions[0].type | government |
| authorships[22].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[22].institutions[0].country_code | ES |
| authorships[22].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Evelyn Martinez |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Radiotherapy, Institut Català d'Oncologia, Idibell, Barcelona, Spain |
| authorships[23].author.id | https://openalex.org/A5087525963 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-0613-2261 |
| authorships[23].author.display_name | Jordi Ponce |
| authorships[23].countries | ES |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[23].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Gynecology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[23].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[23].institutions[0].ror | https://ror.org/00epner96 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[23].institutions[0].country_code | ES |
| authorships[23].institutions[0].display_name | Bellvitge University Hospital |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Jordi Ponce |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Gynecology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[24].author.id | https://openalex.org/A5064980405 |
| authorships[24].author.orcid | https://orcid.org/0000-0001-7119-4031 |
| authorships[24].author.display_name | Maria Jesús Pla-Farnós |
| authorships[24].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Maria Jesus Pla |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Pathology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[25].author.id | https://openalex.org/A5028384284 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-1485-5080 |
| authorships[25].author.display_name | Sònia Pernas |
| authorships[25].countries | ES |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210107147 |
| authorships[25].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[25].institutions[0].id | https://openalex.org/I4210107147 |
| authorships[25].institutions[0].ror | https://ror.org/01j1eb875 |
| authorships[25].institutions[0].type | government |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210107147 |
| authorships[25].institutions[0].country_code | ES |
| authorships[25].institutions[0].display_name | Institut Català d'Oncologia |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Sonia Pernas |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia , Idibell, Barcelona Spain. |
| authorships[26].author.id | https://openalex.org/A5032379353 |
| authorships[26].author.orcid | https://orcid.org/0000-0003-1380-2718 |
| authorships[26].author.display_name | Miguel Gil‐Gil |
| authorships[26].countries | ES |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[26].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[26].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[26].institutions[0].ror | https://ror.org/00epner96 |
| authorships[26].institutions[0].type | healthcare |
| authorships[26].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[26].institutions[0].country_code | ES |
| authorships[26].institutions[0].display_name | Bellvitge University Hospital |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Miguel Gil |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Nuclear Medicine, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[27].author.id | https://openalex.org/A5031187796 |
| authorships[27].author.orcid | https://orcid.org/0000-0003-3398-0570 |
| authorships[27].author.display_name | Amparo Garcı́a-Tejedor |
| authorships[27].countries | ES |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I2802050225 |
| authorships[27].affiliations[0].raw_affiliation_string | Multidisciplinary Breast Cancer Unit, Department of Gynecology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| authorships[27].institutions[0].id | https://openalex.org/I2802050225 |
| authorships[27].institutions[0].ror | https://ror.org/00epner96 |
| authorships[27].institutions[0].type | healthcare |
| authorships[27].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I2802050225, https://openalex.org/I4210153292 |
| authorships[27].institutions[0].country_code | ES |
| authorships[27].institutions[0].display_name | Bellvitge University Hospital |
| authorships[27].author_position | last |
| authorships[27].raw_author_name | Amparo Garcia Tejedor |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Multidisciplinary Breast Cancer Unit, Department of Gynecology, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.preprints.org/manuscript/202406.0810/v1/download |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Patient Outcomes at 5 and 10 Years After Neoadjuvant Chemotherapy for Stage II and III Breast Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10183 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.998199999332428 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Breast Cancer Treatment Studies |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2329386257, https://openalex.org/W2503350049, https://openalex.org/W2397616145, https://openalex.org/W2397320258, https://openalex.org/W4324058133, https://openalex.org/W648618910, https://openalex.org/W2989121736, https://openalex.org/W2892677547, https://openalex.org/W2460051703 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.20944/preprints202406.0810.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S6309402219 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Preprints.org |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_lineage_names | Multidisciplinary Digital Publishing Institute |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.preprints.org/manuscript/202406.0810/v1/download |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.20944/preprints202406.0810.v1 |
| primary_location.id | doi:10.20944/preprints202406.0810.v1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S6309402219 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Preprints.org |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_lineage_names | Multidisciplinary Digital Publishing Institute |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.preprints.org/manuscript/202406.0810/v1/download |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.20944/preprints202406.0810.v1 |
| publication_date | 2024-06-13 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2096745115, https://openalex.org/W2097216790, https://openalex.org/W4392977246, https://openalex.org/W1770259999, https://openalex.org/W2063619867, https://openalex.org/W4386485122, https://openalex.org/W2618058692, https://openalex.org/W2902672529, https://openalex.org/W993406450, https://openalex.org/W2075894019, https://openalex.org/W2123591186, https://openalex.org/W4399749910, https://openalex.org/W2120431466, https://openalex.org/W4210452542, https://openalex.org/W3006930853, https://openalex.org/W2111717465, https://openalex.org/W2994903788, https://openalex.org/W2086064725, https://openalex.org/W2902218997, https://openalex.org/W3165313225, https://openalex.org/W2788106879, https://openalex.org/W2029967318, https://openalex.org/W2896597060, https://openalex.org/W2807418950, https://openalex.org/W2774580734, https://openalex.org/W4392295355, https://openalex.org/W2104337757, https://openalex.org/W4298840493, https://openalex.org/W4311018441, https://openalex.org/W2751878655 |
| referenced_works_count | 30 |
| abstract_inverted_index.0 | 208 |
| abstract_inverted_index.3 | 210 |
| abstract_inverted_index.5 | 71, 154 |
| abstract_inverted_index.a | 17, 38, 136, 146, 183, 220, 253 |
| abstract_inverted_index.10 | 73, 156 |
| abstract_inverted_index.II | 45 |
| abstract_inverted_index.In | 106 |
| abstract_inverted_index.at | 70, 153, 248 |
| abstract_inverted_index.in | 3, 21, 62, 199, 224 |
| abstract_inverted_index.is | 16 |
| abstract_inverted_index.it | 15 |
| abstract_inverted_index.of | 19, 42, 102, 140, 149, 185, 233, 255 |
| abstract_inverted_index.on | 56 |
| abstract_inverted_index.or | 155 |
| abstract_inverted_index.p= | 237 |
| abstract_inverted_index.to | 9, 33, 86, 97, 160, 176, 205, 209 |
| abstract_inverted_index.up | 139 |
| abstract_inverted_index.vs | 187, 235, 257 |
| abstract_inverted_index.10y | 202, 231 |
| abstract_inverted_index.126 | 141 |
| abstract_inverted_index.482 | 43 |
| abstract_inverted_index.69% | 214 |
| abstract_inverted_index.III | 47 |
| abstract_inverted_index.RCB | 129, 207 |
| abstract_inverted_index.TNM | 117 |
| abstract_inverted_index.The | 170 |
| abstract_inverted_index.and | 12, 27, 36, 46, 58, 72, 89, 99, 131, 167, 215, 242, 275 |
| abstract_inverted_index.bad | 222 |
| abstract_inverted_index.can | 272 |
| abstract_inverted_index.cut | 123 |
| abstract_inverted_index.for | 83, 163, 189, 239, 260 |
| abstract_inverted_index.log | 78 |
| abstract_inverted_index.may | 28 |
| abstract_inverted_index.off | 124 |
| abstract_inverted_index.our | 225 |
| abstract_inverted_index.pCR | 127, 181 |
| abstract_inverted_index.the | 7, 100, 107, 206, 249 |
| abstract_inverted_index.was | 68, 165, 173, 196, 211 |
| abstract_inverted_index.20%, | 95 |
| abstract_inverted_index.20%; | 125 |
| abstract_inverted_index.75.3 | 166 |
| abstract_inverted_index.95.5 | 186 |
| abstract_inverted_index.DDFS | 203, 232 |
| abstract_inverted_index.Her2 | 64 |
| abstract_inverted_index.TILs | 93 |
| abstract_inverted_index.TNBC | 164, 200 |
| abstract_inverted_index.TNM, | 87 |
| abstract_inverted_index.This | 194 |
| abstract_inverted_index.Tils | 122 |
| abstract_inverted_index.help | 273 |
| abstract_inverted_index.make | 277 |
| abstract_inverted_index.mean | 137 |
| abstract_inverted_index.pCR. | 193 |
| abstract_inverted_index.plus | 60 |
| abstract_inverted_index.rank | 79 |
| abstract_inverted_index.seen | 174 |
| abstract_inverted_index.test | 18, 80 |
| abstract_inverted_index.that | 111 |
| abstract_inverted_index.vivo | 22 |
| abstract_inverted_index.were | 81, 116, 201, 227 |
| abstract_inverted_index.with | 23, 52, 77, 180, 219, 230, 245, 252 |
| abstract_inverted_index.0.001 | 238 |
| abstract_inverted_index.100%, | 212 |
| abstract_inverted_index.42.9% | 234 |
| abstract_inverted_index.49.2% | 216 |
| abstract_inverted_index.59.2% | 256 |
| abstract_inverted_index.72.4% | 188 |
| abstract_inverted_index.73.5, | 168 |
| abstract_inverted_index.83.6, | 258 |
| abstract_inverted_index.After | 135 |
| abstract_inverted_index.Meier | 76 |
| abstract_inverted_index.after | 269 |
| abstract_inverted_index.based | 55 |
| abstract_inverted_index.rates | 151 |
| abstract_inverted_index.stage | 44 |
| abstract_inverted_index.those | 63, 109, 178, 190, 243, 261 |
| abstract_inverted_index.value | 26 |
| abstract_inverted_index.years | 157 |
| abstract_inverted_index.(81.2% | 158 |
| abstract_inverted_index.74.7%) | 161 |
| abstract_inverted_index.79.7%, | 236 |
| abstract_inverted_index.80.6%, | 213 |
| abstract_inverted_index.Kaplan | 75 |
| abstract_inverted_index.breast | 4, 11, 48 |
| abstract_inverted_index.cancer | 5, 49 |
| abstract_inverted_index.cases. | 66 |
| abstract_inverted_index.ductal | 240 |
| abstract_inverted_index.follow | 138 |
| abstract_inverted_index.offers | 6 |
| abstract_inverted_index.series | 226 |
| abstract_inverted_index.single | 40 |
| abstract_inverted_index.tailor | 29 |
| abstract_inverted_index.taxans | 59 |
| abstract_inverted_index.tumors | 144 |
| abstract_inverted_index.years. | 74 |
| abstract_inverted_index.10yDDFS | 184, 254 |
| abstract_inverted_index.Luminal | 143 |
| abstract_inverted_index.cut-off | 94 |
| abstract_inverted_index.factors | 110 |
| abstract_inverted_index.lobular | 228 |
| abstract_inverted_index.months, | 142 |
| abstract_inverted_index.outcome | 115 |
| abstract_inverted_index.patient | 114, 274 |
| abstract_inverted_index.special | 221 |
| abstract_inverted_index.subtype | 120 |
| abstract_inverted_index.treated | 51 |
| abstract_inverted_index.whereas | 162 |
| abstract_inverted_index.without | 192, 263 |
| abstract_inverted_index.Material | 35 |
| abstract_inverted_index.Methods: | 37 |
| abstract_inverted_index.Patients | 218 |
| abstract_inverted_index.Results: | 105 |
| abstract_inverted_index.Survival | 67 |
| abstract_inverted_index.adjuvant | 30 |
| abstract_inverted_index.antiHEr2 | 61 |
| abstract_inverted_index.axillary | 13 |
| abstract_inverted_index.compared | 159 |
| abstract_inverted_index.greatest | 171 |
| abstract_inverted_index.invasion | 133, 247 |
| abstract_inverted_index.outcomes | 268 |
| abstract_inverted_index.p=0.,000 | 259 |
| abstract_inverted_index.patients | 50, 179, 191, 244, 262 |
| abstract_inverted_index.positive | 65 |
| abstract_inverted_index.presence | 101 |
| abstract_inverted_index.response | 96, 177 |
| abstract_inverted_index.specimen | 251 |
| abstract_inverted_index.subtype, | 92 |
| abstract_inverted_index.surgery, | 14 |
| abstract_inverted_index.surgical | 250 |
| abstract_inverted_index.survival | 150 |
| abstract_inverted_index.vascular | 103, 132, 246, 264 |
| abstract_inverted_index.(p=0.000) | 130 |
| abstract_inverted_index.according | 32, 85, 175, 204 |
| abstract_inverted_index.achieving | 126 |
| abstract_inverted_index.clinician | 276 |
| abstract_inverted_index.invasion. | 104, 265 |
| abstract_inverted_index.long-term | 113, 267 |
| abstract_inverted_index.molecular | 90 |
| abstract_inverted_index.presented | 145, 182 |
| abstract_inverted_index.prognosis | 223 |
| abstract_inverted_index.response. | 34 |
| abstract_inverted_index.treatment | 31 |
| abstract_inverted_index.(p=0.000), | 128 |
| abstract_inverted_index.(p=0.000). | 134 |
| abstract_inverted_index.(p=0.000); | 118 |
| abstract_inverted_index.(p=0.003); | 121 |
| abstract_inverted_index.calculated | 69, 82, 152 |
| abstract_inverted_index.carcinomas | 229 |
| abstract_inverted_index.decisions. | 279 |
| abstract_inverted_index.difference | 84, 148, 172, 195 |
| abstract_inverted_index.especially | 197 |
| abstract_inverted_index.facilitate | 10 |
| abstract_inverted_index.influenced | 112 |
| abstract_inverted_index.meaningful | 198 |
| abstract_inverted_index.pathologic | 119 |
| abstract_inverted_index.prognostic | 25 |
| abstract_inverted_index.surrogated | 91 |
| abstract_inverted_index.univariate | 108 |
| abstract_inverted_index.Conclusion: | 266 |
| abstract_inverted_index.Neoadjuvant | 1 |
| abstract_inverted_index.carcinomas; | 241 |
| abstract_inverted_index.institution | 41 |
| abstract_inverted_index.neoadjuvant | 53, 270 |
| abstract_inverted_index.possibility | 8 |
| abstract_inverted_index.significant | 24 |
| abstract_inverted_index.substantial | 147 |
| abstract_inverted_index.chemotherapy | 2, 54, 98, 271 |
| abstract_inverted_index.pathological | 88 |
| abstract_inverted_index.Introduction: | 0 |
| abstract_inverted_index.anthracycline | 57 |
| abstract_inverted_index.respectively. | 169, 217 |
| abstract_inverted_index.retrospective | 39 |
| abstract_inverted_index.well-informed | 278 |
| abstract_inverted_index.chemosensibility | 20 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5059890986 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 28 |
| corresponding_institution_ids | https://openalex.org/I4210107147 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.62767173 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |